Skip to main content

Jefferies Financial Group Inc.

Position in ABT — Abbott Laboratories

CIK 96223 NEW YORK, NY

Position in ABT

as of Mar 31, 2026 · filed May 8, 2026
Position Value
$15,698,140
+$8,178,861 QoQ
Shares Held
152,899
+154.8% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ABT Over Time

Shares Held

Position Value (USD)

Derivatives in ABT

reported options exposure · as of Jun 30, 2024
CallValue
$810,498
CallShares
7,800
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

Jefferies Financial Group Inc. holds $78,811,499 across 24 Medical Devices names. ABT ranks #2 (19.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 ABT
Abbott Laboratories
This page
152,899 $15,698,140

All Filings in ABT

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $15,698,140 152,899
2025-12-31 $7,519,279 60,015
2025-09-30 $6,836,431 51,041
2025-06-30 $5,387,628 39,612
2025-03-31 $32,306,642 243,548
2024-12-31 $22,577,773 199,609
2024-09-30 $8,638,081 75,766
2024-06-30 $810,498 7,800
2024-06-30 $16,624,872 159,993
2024-03-31 $33,959,675 298,783
2023-12-31 $12,578,249 114,275
2023-12-31 $3,236,058 29,400
2023-12-31 $2,476,575 22,500
2023-09-30 $10,266,100 106,000
2023-09-30 $4,338,880 44,800
2023-09-30 $16,689,192 172,320
2023-06-30 $11,686,944 107,200
2023-06-30 $22,893,000 209,989
2023-06-30 $2,267,616 20,800
2023-03-31 $19,239,400 190,000
2023-03-31 $29,258,266 288,942
2023-03-31 $13,194,178 130,300
2022-12-31 $12,109,837 110,300
2022-12-31 $19,597,515 178,500
2022-12-31 $28,766,956 262,018